- Division of Physiological and Pathological Sciences – DPPS
- Review Branch:
- Immunology and Infectious Diseases B – IIDB
- Study Section:
- HIV Comorbidities and Clinical Studies Study Section – HCCS
Dr. David Chang received his Ph.D. from the Uniformed Services University of the Health Sciences, where he studied connections between the HIV-1 envelope glycoprotein, broadly neutralizing antibodies, and disease progression. In addition, he developed a novel replication-competent alphavirus expression vector based on Fort Morgan virus. He then joined the U.S. Military HIV Research Program, Walter Reed Army Institute of Research, as a research scientist in the Laboratory of Molecular Virology and Pathogenesis, investigating the molecular epidemiology of HIV in Asia and Africa and developing full-genome infectious molecular clones of HIV. He also collaborated in the characterization of CNS compartmentalization during acute HIV infection. Dr. Chang has experience from biotech, focusing on pre-clinical viral vaccine development. He comes to CSR after serving as a Scientific Review Officer at National Institute of Allergy and Infectious Diseases.